- Home
- MAIA vs TTOO Comparison
MAIA vs TTOO Comparison
Compare MAIA & TTOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAIA
- TTOO
- Stock Information
- Founded
- MAIA 2018
- TTOO 2006
- Country
- MAIA United States
- TTOO United States
- Employees
- MAIA N/A
- TTOO N/A
- Industry
- MAIA Biotechnology: Pharmaceutical Preparations
- TTOO Medical/Dental Instruments
- Sector
- MAIA Health Care
- TTOO Health Care
- Exchange
- MAIA Nasdaq
- TTOO Nasdaq
- Market Cap
- MAIA 62.4M
- TTOO 36.4M
- IPO Year
- MAIA 2022
- TTOO 2014
- Fundamental
- Price
- MAIA $2.82
- TTOO $0.97
- Analyst Decision
- MAIA
- TTOO Hold
- Analyst Count
- MAIA 0
- TTOO 1
- Target Price
- MAIA N/A
- TTOO $5.00
- AVG Volume (30 Days)
- MAIA 60.0K
- TTOO 710.5K
- Earning Date
- MAIA 11-05-2024
- TTOO 11-13-2024
- Dividend Yield
- MAIA N/A
- TTOO N/A
- EPS Growth
- MAIA N/A
- TTOO N/A
- EPS
- MAIA N/A
- TTOO N/A
- Revenue
- MAIA N/A
- TTOO $7,164,000.00
- Revenue This Year
- MAIA N/A
- TTOO $50.31
- Revenue Next Year
- MAIA N/A
- TTOO $117.92
- P/E Ratio
- MAIA N/A
- TTOO N/A
- Revenue Growth
- MAIA N/A
- TTOO N/A
- 52 Week Low
- MAIA $0.82
- TTOO $0.90
- 52 Week High
- MAIA $5.99
- TTOO $8.38
- Technical
- Relative Strength Index (RSI)
- MAIA 50.98
- TTOO 18.34
- Support Level
- MAIA $2.36
- TTOO $0.90
- Resistance Level
- MAIA $2.72
- TTOO $1.86
- Average True Range (ATR)
- MAIA 0.22
- TTOO 0.15
- MACD
- MAIA 0.02
- TTOO -0.00
- Stochastic Oscillator
- MAIA 72.28
- TTOO 5.72
About MAIA MAIA Biotechnology Inc.
MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company. The company develops targeted immunotherapies for cancer. The company is an immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's program is THIO, a potential cancer telomere-targeting agent in clinical development for the treatment of telomerase-positive cancer cells.
About TTOO T2 Biosystems Inc.
T2 Biosystems Inc is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes. It is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. The company's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the proprietary T2 Magnetic Resonance technology.